TRUETIVA - Trademark Details
Status: 700 - Registered
Serial Number
88577034
Registration Number
6610505
Word Mark
TRUETIVA
Status
700 - Registered
Status Date
2022-01-11
Filing Date
2019-08-13
Registration Number
6610505
Registration Date
2022-01-11
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-10-26
Attorney Name
Law Office Assigned Location Code
N40
Employee Name
LEE, REBECCA ANN
Statements
Goods and Services
Pharmaceutical agents affecting metabolism; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Plant extracts for pharmaceutical purposes; all of the foregoing goods containing CBD being solely derived from hemp with a delta-9 tetrahyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Goods and Services
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; any CBD in the goods being featured or provided in the aforementioned services being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-08-28
Primary Code
042
First Use Anywhere Date
2017-11-30
First Use In Commerce Date
2018-12-20
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Curtis Wadsworth
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-08-16 | NEW APPLICATION ENTERED IN TRAM |
2019-08-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-11-12 | ASSIGNED TO EXAMINER |
2019-11-12 | ASSIGNED TO EXAMINER |
2020-08-06 | ASSIGNED TO EXAMINER |
2020-08-11 | NON-FINAL ACTION WRITTEN |
2020-08-11 | NON-FINAL ACTION E-MAILED |
2020-08-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-02-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-10 | FINAL REFUSAL WRITTEN |
2021-03-10 | FINAL REFUSAL E-MAILED |
2021-03-10 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-09-21 | EXAMINERS AMENDMENT -WRITTEN |
2021-09-21 | EXAMINERS AMENDMENT E-MAILED |
2021-09-21 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-09-21 | EXAMINER'S AMENDMENT ENTERED |
2021-09-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-10-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-10-26 | PUBLISHED FOR OPPOSITION |
2021-10-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2022-01-11 | REGISTERED-PRINCIPAL REGISTER |